# Summit Therapeutics Inc. (SMMT): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/smmt for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

Summit Therapeutics Inc. is a biopharmaceutical firm dedicated to discovering, developing, and commercializing therapeutic solutions, primarily targeting infectious diseases across the United States and Latin America. The company's clinical development pipeline is heavily concentrated on therapies for Clostridioides difficile infection (CDI). Its flagship product candidate, ridinilazole, is an orally administered small molecule antibiotic currently advancing through Phase III clinical trials as a treatment for CDI. Beyond its lead asset, Summit Therapeutics is also progressing SMT-738, desi...

## Quote & Key Metrics

As of 2026-10-23:

| Metric | Value |
|---|---|
| Price | $15.47 USD |
| Market Cap | $12.34B |
| P/E (TTM) | — |
| EPS (TTM) | −$1.12 |
| 52-Week Range | $12.07 – $29.23 |
| Dividend Yield (TTM) | — |

## Dividend

SMMT has no dividend payment history in our records.

## Frequently Asked Questions

### What does Summit Therapeutics Inc. do?

Summit Therapeutics Inc. (SMMT) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is SMMT's market cap?

Summit Therapeutics Inc. (SMMT) has a market capitalization of approximately $12.34 billion, as of October 23, 2026, based on the most recent share price and shares outstanding.

### Does SMMT pay a dividend?

No, Summit Therapeutics Inc. (SMMT) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

### Is SMMT profitable?

Summit Therapeutics Inc. (SMMT) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### Has SMMT ever paid a dividend?

No. Dividend Data's records show no dividend payments from Summit Therapeutics Inc. (SMMT). A first dividend would appear on the Dividend tab once it is declared.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/smmt
- Dividend history & safety: https://www.dividenddata.com/stocks/smmt/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/smmt/earnings
- Financial statements: https://www.dividenddata.com/stocks/smmt/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/smmt/valuation
- Peer comparison: https://www.dividenddata.com/stocks/smmt/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.